Abbott Laboratories (ABT) director receives 347 stock equivalent units as board compensation

Rhea-AI Filing Summary

Abbott Laboratories director Nita Ahuja received a grant of 347 stock equivalent units on Common Shares as director compensation. These units, valued using a reference price of $90.74 per unit, increased her stock equivalent unit balance to 450 units. Director fees are credited to a stock equivalent unit account and are generally paid in cash at about age 65 or upon retirement from the board. The units earn the same return as if the fees were invested in Abbott shares, and the balance also includes units acquired through a dividend reinvestment feature.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ahuja Nita

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Equivalent Units	347	$90.74	$31K

Holdings After Transaction: Stock Equivalent Units — 450 shares (Direct, null)

Footnotes (1)

1. Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Key Figures

Stock equivalent units granted: 347 units Reference price per unit: $90.74 per unit Total stock equivalent units after grant: 450 units +1 more

4 metrics

Stock equivalent units granted 347 units Grant/award acquisition on 2026-06-30

Reference price per unit $90.74 per unit Stock equivalent units linked to common shares

Total stock equivalent units after grant 450 units Balance following transaction

Underlying common shares per unit grant 347 common shares Underlying security for stock equivalent units

Key Terms

Stock Equivalent Units, dividend reinvestment feature, director fees

3 terms

Stock Equivalent Units financial

"Stock Equivalent Units earn the same return as if the fees were invested in Abbott shares."

Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.

dividend reinvestment feature financial

"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."

director fees financial

"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 05:16 PM Accepted by SEC EDGAR 07/01/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ahuja Nita

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	(1)	06/30/2026		A		347		(1)	(1)	Common Shares	347	$90.74	450(2)	D

Explanation of Responses:

1. Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ Nita Ahuja by Jessica H. Paik, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Abbott Laboratories (ABT) director Nita Ahuja report on this Form 4?

Nita Ahuja reported receiving 347 stock equivalent units linked to Abbott common shares as director compensation. These units are credited to a stock equivalent unit account and increase her total balance to 450 units after the transaction, according to the filing details and accompanying footnotes.

What are stock equivalent units in the Abbott Laboratories (ABT) Form 4 filing?

Stock equivalent units are bookkeeping entries that track the value of director fees as if invested in Abbott shares. They earn the same return as Abbott stock, but are generally paid out in cash at about age 65 or upon retirement from the board, per the footnote disclosure.

How many stock equivalent units did Nita Ahuja hold after this Abbott (ABT) transaction?

After the grant of 347 stock equivalent units, Nita Ahuja held a total of 450 stock equivalent units. This balance includes both the newly granted units and additional units acquired through a dividend reinvestment feature, as described in the Form 4 footnotes.

Was the Abbott (ABT) transaction a market purchase or sale of common stock?

No, the transaction was a grant of stock equivalent units classified as a derivative award, not an open-market stock trade. The filing labels the code as a grant or award acquisition, tied to director fees credited to a stock equivalent unit account, rather than a buy or sell order.

How is the value of Abbott (ABT) stock equivalent units determined in this filing?

The units in this filing reference a price of $90.74 per underlying common share. Although paid in cash later, the stock equivalent units earn the same return as if director fees were invested in Abbott shares, aligning their value with the company’s stock performance over time.